Stay updated on Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial

Sign up to get notified when there's something new on the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T11:27:07.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T06:14:49.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The date has been updated from April 18, 2025, to May 21, 2025.
    Difference
    0.7%
    Check dated 2025-05-22T03:47:24.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-04-30T18:06:35.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The date has been updated from February 25, 2025, to April 18, 2025.
    Difference
    0.7%
    Check dated 2025-04-23T15:48:42.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.15.0 from version 2.14.4, indicating a revision in the content.
    Difference
    1.0%
    Check dated 2025-04-16T13:07:41.000Z thumbnail image

Stay in the know with updates to Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Galcanezumab in Chronic Migraine Ages 12-17 Clinical Trial page.